No Data
No Data
Boston Scientific Sees Deal Slightly Dilutive to Adj EPS in 2025 >BSX
Boston Scientific: Buyout to Expand Cardiovascular Portfolio With Complementary, Differentiated Calcium Modification Platform >BSX
Positive Long-Term Outlook for Boston Scientific Post-Axonics Acquisition: Buy Rating Affirmed
Boston Scientific Enters Definitive Deal To Acquire Bolt Medical; Transaction Consists Of Upfront Payment Of $443M For The 74% Stake Not Yet Owned
Express News | Boston Scientific Corp - Deal Valued at $443 Million Upfront, up to $221 Million in Milestones
Express News | Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.